NEXENTIS TECHNOLOGIES INC. Capital Expenditures
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Capital Expenditures of $72.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.00K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $71.00K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $4.10K, a 92.18% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $20.63K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2025 was $14.00K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2022 was $51.69K, a 23.71% decline from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2021 was $67.75K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire property, plant, and equipment for fiscal 2019 was $23.33K, a 822.38% increase from fiscal 2018.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $72.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $71.00K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $14.00K 10-K · filed 2026-03-31 | |||
| 2022-12-31 | $4.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $24.72K derived: sum of 2 quarters · filed 2024-04-01 | $33.83K derived: sum of 3 quarters · filed 2024-04-01 | $51.69K 10-K · filed 2024-04-01 |
| 2022-09-30 | $20.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $29.73K derived: sum of 2 quarters · filed 2023-11-14 | $47.59K 10-Q · filed 2023-11-14 | $99.98K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $9.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $26.97K 10-Q · filed 2023-08-14 | $79.36K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $17.86K 10-Q · filed 2023-05-15 | $70.26K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $52.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $67.75K 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $15.36K 10-Q · filed 2022-11-14 | |||
| 2019-12-31 | $18.41K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $23.33K 10-K · filed 2021-03-29 | ||
| 2019-09-30 | $4.92K 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $2.53K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |